Loading clinical trials...
Loading clinical trials...
TTN is the most common respiratory disorder in the perinatal period, causing 40% of cases of respiratory distress after birth. Lung fluid absorption is initiated by beta-adrenergic agonists, such as e...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tishreen University
NCT07081412 · Overactive Bladder Syndrome, Overactive Bladder (OAB), and more
NCT01403402 · Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency, Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy), and more
NCT05527704 · TTN, Respiratory Failure, and more
NCT06921291 · TTN
NCT04546321 · Compare Between the Serum Level of Lcarnitine in HIE Cases and TTN
Latakia University
Latakia, Latakia Governorate
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions